Tail Anchored protein insertion mediated by CAML and TRC40 links to neuromuscular function in mice
PLOS Genetics · 2025
DOI: 10.1371/journal.pgen.1011547 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2025. Verfasst von Ying Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st St. SW, Rochester, Minnesota 55905, United States of America. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neurons, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and progressive bulbar palsy, involve loss of muscle control resulting from death of motor neurons. Although the exact pathogenesis of these syndromes remains elusive, many are caused by genetically inherited mutations. Thus, it is valuable to identify additional genes that can impact motor neuron survival and function. In this report, we describe mice that express globally reduced levels of calcium-modulating cyclophilin ligand (CAML) protein. CAML is an essential component in the transmembrane domain recognition complex (TRC) pathway, responsible for inserting C-terminal tail anchored (TA) proteins into the endoplasmic reticulum membrane. The primary phenotype observed in these mice was rapid development of hind limb weakness and paralysis. Spinal cord sections revealed a loss of motor neuron cell bodies. Targeting CAML loss specifically to neurons using SLICK-H-Cre or synapsin-Cre transgenic mice yielded similar phenotypes, indicating that CAML plays a cell autonomous role in this process. We found that intracellular trafficking was perturbed in cells depleted of CAML, with aberrant release of procathepsin D and defective retention of CD222 within the trans-Golgi network, as well as reduced levels and mislocalization of syntaxin 5 (Stx5). Dysfunctional lysosomes and abnormal protein glycosylation were also revealed in CAML deficient cells, further indicating a defect in Golgi trafficking. In addition, we observed an identical phenotype in mice lacking ASNA1 in neurons, suggesting that CAML’s role in sustaining muscle function is related to its involvement in the TRC pathway. Together, these findings implicate motor neuron survival as a key role for the TA protein insertion machinery in mice, which may shed light on the pathogenesis of neuromuscular disease in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st St. SW, Rochester, Minnesota 55905, United States of America.
- Mayo Clinic Alix School of Medicine, 200 1st St. SW, Rochester, Minnesota 55905, United States of America.
- Umeå Centre for Molecular Medicine, Umeå University, SE-901 87 Umeå, Sweden.
- Department of Immunology, Mayo Clinic College of Medicine, 200 1st St. SW, Rochester, Minnesota 55905, United States of America.
ORCID-Profile: Ying Zhang, Anjie Ge, Helena Edlund, Richard J Bram
Zitieren
APA
Zhang, Y., He, L., Gundelach, J., Ge, A., Edlund, H., Norlin, S., & Bram, R. J. (2025). Tail Anchored protein insertion mediated by CAML and TRC40 links to neuromuscular function in mice. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011547
Vancouver
Zhang Y, He L, Gundelach J, Ge A, Edlund H, Norlin S, et al. Tail Anchored protein insertion mediated by CAML and TRC40 links to neuromuscular function in mice. PLOS Genetics. 2025. doi:10.1371/journal.pgen.1011547
BibTeX
@article{Zhang2025,
author = {Zhang, Ying and He, Lihong and Gundelach, Justin and Ge, Anjie and Edlund, Helena and Norlin, Stefan and Bram, Richard J},
title = {Tail Anchored protein insertion mediated by CAML and TRC40 links to neuromuscular function in mice},
journal = {PLOS Genetics},
year = {2025},
doi = {10.1371/journal.pgen.1011547}
}
EUVIMED